Coherus BioSciences, Inc. (CHRS): Price and Financial Metrics
CHRS Price/Volume Stats
| Current price | $0.95 | 52-week high | $2.64 |
| Prev. close | $0.91 | 52-week low | $0.66 |
| Day low | $0.90 | Volume | 3,530,900 |
| Day high | $0.97 | Avg. volume | 1,984,408 |
| 50-day MA | $1.16 | Dividend yield | N/A |
| 200-day MA | $1.27 | Market Cap | 109.68M |
CHRS Stock Price Chart Interactive Chart >
Coherus BioSciences, Inc. (CHRS) Company Bio
Coherus Biosciences is a pure-play biosimilar platform company that develops and commercializes high-quality therapeutics for major regulated markets. The company was founded in 2010 and is based in Redwood City, California.
CHRS Price Returns
| 1-mo | -15.18% |
| 3-mo | -37.50% |
| 6-mo | -6.86% |
| 1-year | -61.69% |
| 3-year | -92.19% |
| 5-year | -93.14% |
| YTD | -31.16% |
| 2024 | -58.56% |
| 2023 | -57.95% |
| 2022 | -50.38% |
| 2021 | -8.17% |
| 2020 | -3.47% |
Continue Researching CHRS
Want to do more research on Coherus BioSciences Inc's stock and its price? Try the links below:Coherus BioSciences Inc (CHRS) Stock Price | Nasdaq
Coherus BioSciences Inc (CHRS) Stock Quote, History and News - Yahoo Finance
Coherus BioSciences Inc (CHRS) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...